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Abstract
Background: Propolis is a natural, resinous hive product that has several pharmacological activities. Its composition
varies depending on the vegetation, climate, season and environmental conditions of the area from where it was
collected. Surface enhanced laser desorption ionization time of flight mass spectrometry (SELDI-TOF MS) is a
proteomic approach which has been used in cancer proteomics studies. Prostate cancer is one of the most
commonly diagnosed cancers in men. It has shown that nutritional supplements rich in polyphenolic compounds
such as propolis play a significant role in prostate cancer chemoprevention. The aim of this study is to evaluate if
protein expression profile in PC-3 prostate cancer cell lines could be differentiated when incubated with dimethyl
sulfoxide and water extracts of Turkish propolis.
Results: The antioxidant potentials of dimethyl sulfoxide and water extracts of propolis were found in correlation
with the amount of total phenolic compounds of them. Dimethyl sulfoxide and water extracts of propolis of 20
μg/mL reduced the cell viability to 24.5% and 17.7%, respectively. Statistically significant discriminatory peaks
between control PC-3 cells and dimethyl sulfoxide extract of propolis-treated PC-3 cells were found to be the
proteomic features at m/z 5143, 8703, 12661, 20184 and 32794, detected by CM10 ProteinChip, and the peak at m/
z 3772, detected by Q10 ProteinChip. Between control PC-3 cells and water extract of propolis-treated PC-3 cells,
statistically significant discriminatory peaks were found to be the proteomic features at m/z 15846, 16052 and
24658, detected by CM10 ProteinChip and the peaks at m/z 10348, 10899 and 11603, detected by Q10
ProteinChip.
Conclusions: It was concluded that dimethyl sulfoxide and water extracts of Turkish propolis may have anti-
proliferative activity through differentiating protein expression profile in PC-3 prostate cancer cell lines along with
their antioxidant capacity.
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Background
Propolis is a natural, resinous hive product that honey-
bees manufacture by mixing their own waxes and sali-
vated secretions with resins collected from the resin
from the cracks in the bark of trees and leaf buds [1-4].
The chemical composition of propolis depends on the
vegetation, climate, season and environmental condi-
tions of the area from where it was collected [1,5]. It is
mainly composed of resin and vegetable balsam (50%),
wax (30%), essential and aromatic oils (10%), pollen
(5%), and other various substances including organic
compounds and minerals (5%) [3,5,6]. Organic com-
pounds that are identified in different propolis samples
are fatty and phenolic acids and esters, substituted phe-
nolic esters, flavonoids (flavones, flavanones, flavonols,
dihydroflavonols, chalcones), terpenes, b-steroids, aro-
matic aldehydes and alcohols, sesquiterpenes, naphtalene
and stilbene derivatives [7,8]. Propolis has a long history
for being used in folk medicine and includes various
biological activities such as anti-microbial, anti-tumor,
anti-bacterial, anti-fungal, anti-viral, anti-inflammatory,
anti-oxidant, anti-cancer, anti-protozoan, cariostatic,
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Biological actions of propolis are generally attributed to
phenolic compounds in its content [5,8]. Anti-tumoral
activity of propolis might be attributed to a single sub-
stance, or to synergistic effects of several compounds, or
to potential metabolites. On the other hand, poor activ-
ity might be due to antagonistic effects of its compo-
nents or the absence or low concentration of active
substances [10]. Propolis has been used in food and bev-
erages, and is thought to improve health and prevent
diseases such as inflammation, heart disease, diabetes
and cancer [2,11,12].
The term ‘’proteome’’ describes ‘’all proteins expressed
by the genome of a cell, a tissue or an organism’’ and
was introduced by Marc Wilkins [13,14]. In contrast to
the genome, the proteome is dynamic collection of pro-
teins that represents both the intrinsic genetic pro-
gramme of the cell and and the impact of its immediate
environment [14,15]. Thus, the proteome provides a
more realistic view of a biological status compared with
the genome. Proteome is expected to be more useful
than genome to evaluate disease presence, progression
and response to treatment [14]. Proteomics is a scienti-
fic approach used to elucidate all protein species within
a cell or tissue [16]. During the transformation of a
healthy cell into a neoplastic cell, distinct changes occur
at the protein level such as altered expression, differen-
tial protein modification, changes in specific activity,
and aberrant localization. Researchers propose to iden-
tify and understand these changes by cancer proteomics
studies [15]. Recently, new strategies that facilitate pro-
teomic analysis, such as, the surface-enhanced laser des-
orption ionization time-of-flight mass spectrometry
(SELDI-TOF-MS) have been introduced [17]. This tech-
nology uses protein chips made of a variety of chroma-
tographic surfaces to capture proteins from a complex
mixture that are subsequently ionized and detected by
TOF MS and provides a peak whose intensity is rela-
tively quantitative and reproducible measure of a parti-
cular protein [16,18,19]. Changes in the protein peaks,
or m/z ratios within the spectra, can be used to identify
protein changes that may underlie in pathophysiological
processes. Alternatively, SELDI can also be used to gen-
erate peptide mass fingerprint (PMFs) from a complex
protein sample, which is then compared to theoretical
PMFs of known and DNA sequence-derived whole pro-
teins contained within databases [16]. SELDI-TOF MS
allows protein profiling from a variety of complex biolo-
gical materials such as serum, blood, plasma, intestinal
fluid, urine, cell lysates and cellular secretion products
[19]. SELDI has several advantages because of its high
throughput, versatility, ease of use. It is rapid, reproduci-
ble, highly sensitive (detection limit in the femtomolar
range) and readily adaptable to a diagnostic format
[14,15]. But it is unsuitable for high molecular weight
proteins (> 100 kDa); limited to detection of bound pro-
teins; lower resolution and mass accuracy [14].
Prostate cancer is one of the most commonly diag-
nosed cancers in men and develops in nearly 30% of
all men above the age of 50 years [20,21]. Prostate can-
cer may metastasize to other parts of the human body,
especially bones and lymph nodes [21]. The factors
that determine the risk of developing clinical prostate
cancer have been identified as increasing age, ethnicity,
and heredity [22]. Multiple genes and additional envir-
onmental factors such as diet and inflammation are
also involved in the pathogenesis of prostate cancer.
Furthermore, marked geographic variations have been
observed in the incidence of clinical prostate cancer
[23]. In the treatment of prostate cancer, many che-
motherapeutic agents such as Eulexin, Flutamide and
Nilandron have been developed. However, undesirable
side effects such as urinary incontinence and erectile
dysfunction can reduce the therapeutic efficacy of
prostate cancer [21]. Recent studies have shown that,
nutritional supplements, such as Vitamin E, Vitamin
D, soybean, green tea, turmeric, vegetables and fruits
or plant extract rich in polyphenolic compounds, play
a significant role in prostate cancer chemoprevention
[20,24].
The major aim of this study is to evaluate if protein
expression profile in PC-3 prostate cancer cell lines
could be differentiated when incubated with dimethyl
sulfoxide (DMSO) and water extracts of Turkish propo-
lis by SELDI-TOF MS.
Results
Total Phenolic Contents and Antioxidant Potentials of
Propolis Extracts
Total polyphenol content, total flavonoid content, Ferric
reducing antioxidant potential (FRAP) and total antioxi-
dant capacities (TAC) of dimethyl sulfoxide extract of
propolis (DEP) and water extract of propolis (WEP)
were determined as mg gallic acid (GA)/g propolis, mg
quercetin (Q)/g propolis, mg trolox (Tro)/g propolis and
mmoltrolox (Tro)/100 g propolis, respectively. Results
were shown in Table 1. The antioxidant potentials of
DEP and WEP were found to correlate with the amount
of total phenolic compounds in them.
PC-3 Cell Viability and Anti-proliferative Effect of Propolis
Extracts
The cell viability of DMSO solutions-, DMSO extract of
propolis (DEP)- and water extract of propolis (WEP)-
treated PC-3 cells were determined. Results shown in
Table 2. DMSO and water extracts of propolis of 20 μg/
mL, and 0.008% DMSO solution reduced the cell viabi-
lity to 24.5%, 17.7% and 75.0%, respectively.
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propolis-treated and untreated PC-3 cancer cell lines by
SELDI-TOF-MS
As summarised in Table 3 statistically significant discri-
minatory peaks between control PC-3 cells and DMSO
extract of propolis-treated PC-3 cells were found to be
the proteomic features at m/z 5143, 8703, 12661, 20184
and 32794, detected by CM10 ProteinChip, and the
peak at m/z 3772, detected by Q10 ProteinChip. The
expression level of the discriminatory proteomic feature
with m/z 8703 is shown in Figure 1. The visual compar-
ison of intensities of the peak at 8703 between DEP-
treated and untreated PC-3cell lines are shown as box
plot display in Figure 2.
Expression Difference Mapping between water extract of
propolis-treated and untreated PC-3 cancer cell lines by
SELDI-TOF-MS
As shown in Table 4, statistically significant discrimina-
tory peaks between control PC-3 cells and water extract
of propolis-treated PC-3 cells were found to be the pro-
teomic features at m/z 15846,16052 and 24658, detected
by CM10 ProteinChip and the peaks at m/z 10348,
10899 and 11603, detected by Q10 ProteinChip.
Intensities of these selected peaks in profiling data
were changed by treatment with propolis extracts. The
expression levels of two of these significantly discrimina-
tory proteomic features with m/z 15846 and 16052 are
shown in Figure 3. The visual comparison of intensities
of these two peaks at 15846 and 16052, between WEP-
treated and untreated PC-3 cell lines are shown as box
plot display in Figure 4. The expression level of the sig-
nificantly discriminatory proteomic feature with m/z
11603 is shown in Figure 5. The visual comparison of
intensities of the peak at 11603 between WEP-treated
and untreated PC-3 cell lines are shown as box plot dis-
play in Figure 6.
Discussion
Diet and dietary factors play an important role in pre-
venting and treating chronic diseases including cancer
[5,25]. Depending on their isolation step, plant products
have been defined as food, food supplement, functional
food and nutraceuticals. Pure extracted phytomolecule is
named as nutraceuticals, whereas semipurified plant
product is named as functional food.
Micronutrients, polyunsaturated fatty acids, and sec-
ondary metabolites such as glucosinolates, flavonoids,
polyphenols, phytoestrogens, phytosterols, lignans, ter-
penes and phytates are components of these plant foods
[26].
Curcumin (turmeric), capsaicin (green chilies), epigal-
locatechingallate (green tea), gingerol (ginger), genistein
(soya beans), resveratrol (grapes), caffeic acid phenyl
ester (propolis from honey bee), sulforaphane (crucifer-
ous vegetables), silibinin, indole-3-carbinol (cabbage),
apigenin (tea, cabbage, garlic), allicin (garlic), lycopene
(tomatoes), quercetin (rhododendron cinnabarium), and
b-carotene are some of the phytochemicals that are
related to tumor prevention [26].
Thus, natural and synthetic compounds that can be
used in the prevention and/or treatment of cancer are
the targets of researchers [25]. The beehive products
such as honey, propolis, pollen and royal jelly may be
included into functional foods [5].
Reactive oxygen species (ROS) together with other
factors are responsible for cellular aging, cell signalling,
stress responses, cell proliferation, and many conditions
such as cardiovascular diseases, diabetes, arthritis, Par-
kinson disease, Alzheimer and cancer development
[27,28].
The antioxidants serve as a defensive factor against
free radicals; thereby protect lipids and other com-
pounds during oxidative damage. Propolis has been
shown to be capable of scavenging free radicals through
their pharmacologically active constituents such as fla-
vonoids [27]. Thus, propolis is thought to improve
health and prevent diseases such as inflammation, heart
Table 1 Total Phenolic Contents and Antioxidant
Potentials of Propolis Extracts (mean ± standard
deviation)
DEP WEP
Total polyphenol content
(mg GA/g propolis)
48.7 ± 7.8 9.2 ± 0.5
Total flavonoid content
(mg Q/g propolis)
13.0 ± 1.6 2.1 ± 1.5
Ferric Reducing Antioxidant Potential
(FRAP)
(mg Tro/g propolis)
59.5 ± 17.3 24.1 ± 6.1
Total antioxidant capacities
(mmolTro/100 g propolis)
8.8 ± 3.0 5.0 ± 0.8
DEP refers to DMSO (100%) extract of propolis; WEP refers to water extract of
propolis.
Table 2 PC-3 Cell Viability and Anti-proliferative Effect of
Propolis Extracts.
Propolis Extracts/DMSO Solutions Cell Viability %
20 μg/ml DEP 24.5 ± 2.8
10 μg/ml DEP 35.1 ± 16.9
5 μg/ml DEP 50.0 ± 20.5
% 0,008 DMSO 75.0 ± 16.6
% 0,004 DMSO 71.8 ± 21.4
% 0,002 DMSO 72.7 ± 19.3
20 μg/ml WEP 17.7 ± 11.9
10 μg/ml WEP 26.4 ± 8.5
5 μg/ml WEP 29.8 ± 12.8
DEP refers to DMSO (100%) extract of propolis; WEP refers to water extract of
propolis.
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Page 3 of 11disease, diabetes and cancer by its antioxidant potential
[2]. Anti-tumoral activity of propolis might be attributed
to a single substance, or to synergistic effects of several
compounds, or to potential metabolites [10].
Aliyazıcıoğlu et al. found that fluorescence positivity
decreased (between 3.8% and 11.8%) as concentrations
of both dimethyl sulfoxide (DMSO) extracts of propolis
and pollen increased for K-562 cell culture, but
unchanged (between 20% and 83%) for mononuclear
cell (MNC) culture by intracellular dichlorofluorescence
(DCFH) test by using flow-cytometric fluorescence ana-
lysis. They concluded that DMSO extracts of pollen and
propolis inhibited the respiratory burst within cancer
cell lines probably by their antioxidant potentials [28].
It has been reported that various activities of propolis
may be attributed to a synergism between phenolic (fla-
vonoids, aromatic acids and esters) and other com-
pounds in the resin [7,9]. Thus we preferred to use
whole DMSO and water extracts of propolis, rather than
its constituents for our study.
Dimethyl sulfoxide (DMSO) is an amphipathic mole-
cule and soluble in both aqueous and organic media.
Due to its physiochemical properties, DMSO is a very
efficient solvent for water-insoluble compounds and has
been used successfully in the treatment of dermatologi-
cal, urinary, pulmonary, rheumatic and renal manifesta-
tions of amyloidosis. Basically through its anti-
inflammatory and reactive oxygen species scavenger
actions, its use has been purposed in several gastroin-
testinal diseases [29].
Banskota et al. showed that methyl alcohol (MeOH)
extract of the Netherlands propolis had anti-proliferative
activity toward highly liver-metastatic murine colon 26-
L5 carcinoma (EC50, 3.5 mg/mL). They also showed that
the compounds isolated from the MeOH extract (benzyl,
phenethyl and cinnamylcaffeates) possessed potent anti-
proliferative activities with EC50 values of 0.288, 1.76
and 0.114 mM, toward colon 26-L5 carcinoma. Thus,
they concluded that anti-oxidative activity of these caffe-
ates may play an important role in their anti-prolifera-
tive activities [12].
Russo et al. found that compounds obtained in etha-
nolic extract of Chilean propolis such as galangin, caffei-
cacid, p-cumaric acid, ferulic acid and caffeic acid
phenethyl ester (CAPE) by HPLC analysis exhibited
DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical
Table 3 Expression Difference Mapping between DEP-treated and untreated PC-3 cancer cell lines.
Protein
Chip
Proteomic Feature [mean m/z (±
SD)]
p
value
Control PC-3 cells DEP-treated PC-3 cells
Intensity
Average
Intensity
SD
Intensity CV
%
Intensity
Average
Intensity
SD
Intensity CV
%
CM10 5143 (1.9) .0433 9.6 2.7 27.9 7.1 0.6 8.8
8703 (1.0) .0433 22.0 3.2 14.3 32.5 8.2 25.4
12661 (5.4) .0209 13.2 3.4 25.8 14.6 2.8 19.0
20184 (4.8) .0433 1.6 0.8 53.7 0.7 0.2 29.1
32794 (23.7) .0209 0.3 0.0 7.1 0.2 0.0 18.1
Q10 3772 (2.1) .0209 4.5 1.3 29.1 5.9 0.5 7.8
DEP refers to DMSO (100%) extract of propolis; WEP refers to water extract of propolis.
Figure 1 SELDI-TOF mass spectra of DEP-treated and untreated PC-3 cells by CM10 ProteinChip. Protein peaks of the peak 8703 m/z, and
that positively correlated with DEP-treated PC-3 cells.
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Page 4 of 11scavenging and superoxide scavenging activity in a
dose-dependent manner. It was showed that Chilean
propolis exhibited anti-proliferative activity toward KB
cells, Caco-2 and DU-145 cells. The cell viability was
found in the propolis extract treated-KB, -Caco-2 and
-DU145 cells as 9%, 45% and 23%, respectively. They
suggested that the anti-proliferative activity of ethano-
lic extract of Chilean propolis might be mediated by
its ability to modulate intracellular reactive oxygen
species levels [30].
In the study of Li et al. the effects of ethanolic extracts
of Brazilian propolis group l2 and bud resins of botani-
cal origin (B. dracunculifolia), and propolis group 3 on
proliferation of metastasis (DU145 and PC-3) and pri-
mary malignant tumor (RC58T/h/SA#4)-derived from
human prostate cancer cells were evaluated. They found
that the strongest inhibition was observed in propolis
group 3 (sample #3) extracts whereas moderate growth
inhibition was observed in human prostate epithelial
cells. They also found that propolis group 3 (sample #3)
induced growth inhibition (the cells died at 20 μg/mL
treated cells) that was associated with G2 arrest and
showed induction of p21 expression but no inhibition of
cyclin D1, CDK4 (Cyclin-dependent kinase 4) and cyclin
B1 expression. In the RC58T/h/SA#4 cells, they found
that resins of botanical origin of propolis group 12
(sample #1) and propolis group 12 (sample #2) induced
growth inhibition that was associated with S phase
arrest and showed inhibition of cyclin D1, CDK4 and
cyclin B1 expression [31].
Carballo et al. found that Cuban propolis shows cyto-
toxicity in the range of 5-23 μg/mL without cross resis-
tance in both wild-type and chemo-resistant human
tumor cell lines comprising colon, ovarian, and prostate
carcinomas (10 μg/mL and 12.3 μg/mL in PC-3 and
LNCap) as well as neuroblastoma. They assumed that
plukenetione A which was identified for the first time in
Cuban propolis, contributes to the anti-tumoral effect of
C u b a np r o p o l i sm a i n l yb yt a r g e t i n gt o p o i s o m e r a s eIa s
well as DNA polymerase. They also observed that some
Figure 2 Box plot displays of intensity levels of 8703 m/z betweenDEP-treated and untreated PC-3 cells by CM10 ProteinChip.T h e
comparison of DEP-treated PC-3 cell lysates and control PC-3 cell lysates are performed by using non-parametric Mann Whitney method with
Ciphergen Express software, version 3.0.
Table 4 Expression Difference Mapping between WEP-treated and untreated PC-3 cancer cell lines.
Protein
Chip
Proteomic Feature [mean m/z (±
SD)]
p
value
Control PC-3 cells WEP-treated PC-3 cells
Intensity
Average
Intensity
SD
Intensity CV
%
Intensity
Average
Intensity
SD
Intensity CV
%
CM10 15846 (1.4) .0433 8.1 1.6 19.2 10.1 1.2 11.6
16052 (3.5) .0209 3.3 0.5 13.9 4.2 0.6 14.6
24658 (3.9) .0433 1.3 0.2 17.2 1.9 0.5 28.2
Q10 10348 (4.4) .0433 76.5 1.6 2.0 82.0 3.8 4.6
10899 (6.8) .0433 8.5 1.7 20.1 9.8 2.6 26.4
11603 (1.4) .0209 17.3 0.7 4.0 14.8 1.8 27.1
DEP refers to DMSO (100%) extract of propolis; WEP refers to water extract of propolis.
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Page 5 of 11Figure 3 SELDI-TOF mass spectra of WEP-treated and untreated PC-3 cells by CM10 ProteinChip. Protein peaks of the peaks 15846 m/z,
and 16052 m/z that are positively correlated with WEP treatment of PC-3 cells.
Figure 4 Box plot displays of intensity levels of 15846 m/z, and 16052 m/z between WEP-treated and untreated PC-3 cells by CM10
ProteinChip. The comparison of WEP-treated PC-3 cell lysates and control PC-3 cell lysates are performed by using non-parametric Mann
Whitney method with Ciphergen Express software, version 3.0.
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Page 6 of 11components of propolis were more or less active in
the isolated form compared with the whole substance
and evidenced that there was a multiple interaction
(e.g., synergism, antagonism) between propolis consti-
tuents [10].
Wang et al. demonstrated that inhibition of cell
growth and induction of apoptosis in PC-3 cells was sig-
nificantly greater in the combination group (isoflavone
and curcumin) than that could be achieved by either
agent alone. They also found that the effects of those
compounds were associated with decreased Notch-1
expression and DNA binding activity of nuclear factor
kappa B (NF-B) and its target genes such as Cyclin D1,
Bcl-2, and Bcl-xL [32].
In our study, DMSO (100%) extract of propolis was
found to be more rich in polyphenols and flavonoids
according to water extract of propolis and the antioxi-
dant potentials of extracts were found in correlation
with the amount of total phenolic compounds in them.
In this study, we wanted to assess the effect of DMSO
and water extracts of propolis on viability of PC-3 can-
cer cell line by using MTT test. DMSO extracts of pro-
polis at final concentrations of 5, 10, 20 μg/mL reduced
the cell viability more than those of DMSO solutions. It
was shown that water extract of propolis at concentra-
tion of 20 μg/mL had the most cytotoxic activity against
PC-3 cell lines. Our results suggest that anti-proliferative
effect of propolis extracts might be mediated by their
anti-oxidant potentials. According to cell viability
results, 20 μg/mL concentrations of propolis extracts
were chosen to study expression difference mapping by
SELDI-TOF-MS.
Figure 5 SELDI-TOF mass spectra of WEP-treated and untreated PC-3 cells by Q10 ProteinChip. Protein peaks of the peak 11603 m/z, and
that positively correlated with WEP-treated PC-3 cells.
Figure 6 Box plot displays of intensity levels of 11603 m/z between WEP-treated and untreated PC-3 cells by Q10 ProteinChip.T h e
comparison of WEP-treated PC-3 cell lysates and control PC-3 cell lysates are performed by using non-parametric Mann Whitney method with
Ciphergen Express software, version 3.0.
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Page 7 of 11Nair et al. observed that quercetin, flavonoid found in
many fruits and vegetables, and also in propolis, signifi-
cantly inhibited the growth of the highly aggressive PC-
3 prostate cancer cell line and the moderately aggressive
DU-145 prostate cancer cell line, whereas it did not
affect colony formation by the poorly aggressive LNCaP
prostate cancer cell line or the normal fibroblast cell
line BG-9. They found that quercetin significantly
down-regulated the expression of specific oncogenes
and genes controlling G1, S, G2, and M phases of the
cell cycle and up-regulated the expression of several
tumor suppressor genes [33].
In the study of Cheng et al. anti-tumor mechanism of
RhizomaParidis total saponin (RPTS, a component of
herb RhizomaParidis)i nH e p G 2c e l l sw a se x a m i n e db y
a proteomic analysis. They found a significant change
between control (0.01% DMSO) and RPTS (IC50
approximately 10 μg/mL) treated cells after 48 h.
Among twelve proteins that had been identified by
MALDI-TOF-MS (Matrix Assisted Laser Desorption
Ionisation - Time of Flight), six proteins were down-
regulated (dUTPase, hnRNPK, GMPsynthase, etc.) and
six proteins were up-regulated (DNasegamma, Nucleosi-
dediphosphate kinase A, Centrin-2, etc.) by RPTS treat-
ment in HepG2 cells [34].
Lee et al. suggested that caffeic acid phenethyl ester
(CAPE), a chemopreventive phytochemical derived from
honeybee propolis, suppressed SK-Hep1 cell invasion in
a dose-dependent manner by abolishment of matrix
metalloproteinases (MM2 and MM9) which are asso-
ciated with the invasive phenotypes of cancer cells and
inhibition of NF-B DNA-binding activity [35].
Bottoni et al. investigated ciglitazone [PPARg (peroxi-
some proliferators-activated receptor g) agonist]-induced
differentiation of a human hepatocarcinoma HepG2 cell
line, by monitoring cellular parameters of cytodifferen-
tiation and modifications of cellular protein profiles
through 2-DE (Two dimensional electrophoresis) and
MALDI-TOF analysis. They found that ciglitazone is a
strong differentiating agent for the HepG2 cell line and
the proteins of which expression profiles changed,
related to cell antioxidant systems, the cell cycle appara-
tus, signal transduction pathways, cellular stress and
invasiveness [36].
Lee et al. showed that sulforaphane (SFN) which is an
isothiocyanate found in cruciferous vegetables, exerted
cytotoxicity and increased TUNEL (Terminal dUTP nick
end labeling) positive cells in a concentration-dependent
manner in LNCaP prostate cancer cells. In their study,
levels of nine proteins including tubulin b-2, phospho-
glucomutase-3 (PGM3), melanoma-derived leucine zip-
per containing extra-nuclear factor, activin A type I
receptor precursor, smoothelin-A, KIA0073, hypothetical
protein LOC57691 and two unnamed proteins changed
over 8 folds in SFN treated LNCaP cells compared to
untreated control by using MALDI-TOF [21].
Szlıszka et al. demonstrated that TRAIL (tumour
necrosis factor-related apoptosis-inducing ligand)-resis-
tant prostate cancer cells were sensitized by treatment
of ethanolic extract of Brazilian green propolis (EEP) by
enhancing the expression of TRAIL-R2 and the activity
of NF-B in LNCaP cells [20].
In this study, statistically significant discriminatory
peaks between control PC-3 cells and DMSO extract of
propolis-treated PC-3 cells were found to be the proteo-
mic features at m/z 5143, 8703, 12661, 20184 and
32794, detected by CM10 ProteinChip, and the peak at
m/z 3772, detected by Q10 ProteinChip (Table 3).
Between control PC-3 cells and water extract of propo-
lis-treated PC-3 cells, statistically significant discrimina-
tory peaks were found to be the proteomic features at
m/z 15846, 16052 and 24658, detected by CM10 Pro-
teinChip and the peaks at m/z 10348, 10899 and 11603,
detected by Q10 ProteinChip (Table 4). Further study is
required to identify what those proteins are.
Conclusions
It was concluded that DMSO and water extracts of
Turkish propolis might have anti-proliferative activity
through differentiating protein expression profile in PC-
3 prostate cancer cell lines along with their antioxidant
capacity.
Methods
Materials
Dimethylsulfoxide, Sodiumcarbonate, Folin reagent, gal-
licacid, ethanol, aluminium nitrate, potassiumacetate,
quercetin, NaH2PO4.2H2O, Na2HPO4.2H2O, potassium-
ferricyanide, trichloroaceticacid, iron(III) chloride, tro-
lox, TAC kit, DMEM/Ham’sF 1 2+L - g l u t a m i n e ,
penicillin + streptomycin(GIBCO), FBS (FetalBovine
Serum) (SIGMA), Bovine Serum Albumin (SIGMA),
ethylenediaminetetraaceticacid (EDTA), Trypan Blue, 3-
(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbro-
mide, 4-(2-hydroxyethyl)-1-piperazine ethanesulfonica-
cid, glycerol, Triton X-100, urea, Protease Inhibitor
Coctail (SIGMA), 3-((3-Cholamidopropyl)dimethylam-
monio)-1-propanesulfonate, Dithiothreitol, Tris, Ammo-
nium acetate, trifluoroaceticacid, acetonitrile, RPMI
1640 (1× + L-Glutamine), ProteinChipAll-in-One-Pro-
tein Standart II (Bio-Rad), NP20, H50, IMAC30, CM10
(#C57-30075) and Q10(#C57-30080) ProteinChipArrays
(Bio-Rad), SPA (sinapinicacid) (Bio-Rad, SPA0705161)
were used in this study.
Propolis Origin
Propolis samples which were produced by honey-bees
(Apismellifera L.) in various regions of Turkey were
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erative and mixed.
Preparation of Dimethylsulfoxide (DMSO) and Water
Extract of Propolis
Propolis sample was frozen in -80°C and grated. The
grated propolis sample was frozen in-80°C again and
grinded (Retsch, ZM 200). 5 g portions of grinded pro-
polis were dissolved in 20 mL of DMSO (100% w/v) and
water by continuous mixing at 150 rpm and 60°C for 24
h in shaking incubator (Shelleb/Sheldon Mod:514,
USA). After incubation extracts were filtered and centri-
fuged (Eppendorf centrifuge 5810 SN: 11259) at 4000
rpm for 10 min. Collected supernatants were mixed and
stored at +4°C in dark. Then working extracts of propo-
lis at concentrations of 1.25, 2.5, 5.0 and 12.5 mg/mL
were prepared by diluting with water to measure total
polyphenol content, total flavonoid content, ferric redu-
cing antioxidant potential (FRAP) and total antioxidant
capacity (TAC).
Phenolic Content and Antioxidant Potentials of Propolis
Extracts
Determination of Total Polyphenol Content
Total polyphenol content of propolis extracts was deter-
mined spectrophotometrically according to the modified
Folin-Ciocalteu method [37]. The method was adapted
to the 96 well microplatereader. Total phenols in the
propolis extracts were expressed as gallic acid equiva-
lents, using a standard curve of freshly prepared gallic
acid solutions.
Determination of Total Flavonoid Content
Total flavonoid content of propolis extracts was deter-
mined spectrophotometrically by modified aluminum
nitrate colorimetric method that adapted to the 96 well
microplatereader [27]. Total flavonoid content of propo-
lis extracts were expressed as quercetin equivalents,
using a standard curve of freshly prepared quercetin
solutions.
Determination of Ferric Reducing Antioxidant Potential
(FRAP)
The reducing power of propolis extracts was determined
b yt h em e t h o dt h a ti sb a s e do nf e r r i ct of e r r o u si o n
reduction at low pH [27]. The method was adapted to
the 96 well microplatereader. Antioxidant potentials of
propolis extracts were expressed as trolox equivalents,
using a standard curve of freshly prepared trolox
solutions.
Determination of Total Antioxidant Capacity (TAC)
Total antioxidant capacity of propolis extracts was
determined according to a novel colorimetric method
optimised by Erel Ö [38]. TAC was determined by using
TAC kit and the assay results are expressed in mmol-
Trolox/100 gpropolis.
MTT-cell viability assay
PC-3 (ATCC, CRL-1435) cancer cell line was obtained
from the Department of Haematology, Faculty of Med-
icine, GATA, Ankara. PC-3 cells were maintained in
RPMI 1640 and supplemented with 10% FBS, 1% peni-
cillin and streptomycin in T-75 cm
2 flasks at 37°C and
5% CO2 atmosphere. The cell viability was estimated
by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide] assay, which depends on the
reduction of MTT by the mitochondria of living cells
to form a blue formazan product [39]. Then, cells were
plated in DMEM/F:12 medium at a density of 1 × 10
4
cells/well in 96 flat-bottomed well plates. After 24 h
plating, test extracts were added at final concentrations
of 5, 10 and 20 μg/mL DMSO and water extracts of
propolis and 0.008%, 0.004%, 0.002% DMSO/mL
(Extracts were diluted with RPMI 1640). After 24 h
incubation, the medium was replaced with MTT, for
further 4 h incubation. Then the MTT-formazan was
solubilised in DMSO/Ethanol (1:1) and the optical den-
sity was measured at a wavelength of 570 nm in
microplatereader. The experiments were repeated 8
times.
Incubation of PC-3 cancer cell lines with DMSO and water
extracts of propolis
According to MTT-cell viability assay results, PC-3 can-
cer cell lines were incubated with DMSO and water
extracts of propolis at final concentration of 20 μg/mL.
PC-3 cancer cell lines which did not contain extract
were used as control cells. PC-3 cells were incubated for
24 h in DMEM/F:12 supplemented with 1% BSA, 1%
penicillin and streptomycin in T-75 cm
2 flasks at 37°C
and 5% CO2 atmosphere. The experiments were done
thrice.
Lysis of PC-3 cancer cell lines after incubation
After 24 h incubation with water and DMSO extracts
of propolis, treated and untreated PC-3 cells were
lysed by modified HNTG cell lysis procedure [40]. The
DMEM/F:12 medium was removed and cells adhered
to flask were rinsed twice with 5 mL of Phosphate Buf-
fered Saline (PBS, pH 7.4) to remove BSA. Then, cells
were rinsed with 5 mL of ice cold HNG (25 mM
Hepes, 25 mM NaCl, 10% glycerol, pH 7.5). HNG was
completely removed by aspiration and 500 μLo f
HNTG lysis buffer [(25 mM Hepes, 25 mM NaCl, 10%
glycerol, 0.1% Triton X-100, Protease Inhibitor Coctail
(1:1000), pH 7.5] was added on cells to lysis them and
then they were incubated for 10 min on ice. Lysed
cells were transferred to 1.5 mL eppendorf and incu-
bated in thermomixer at 150 rpm and 4°C and centri-
fuged for 10 min at 14.000 g in microcentrifuge. The
supernatants which contain cell proteins were collected
separately and aliquoted and stored at -80°C until
used.
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SELDI-TOF mass spectrometry
To determine the best protein profiles regarding num-
ber and resolution of the protein peaks, four chips with
different ProteinChip surfaces [cationic (CM10), anionic
(Q10), hydrophobic (H50), and Cu metal binding
(IMAC30), CiphergenBiosystems, Fremont, CA, USA]
were tested. Weak cation exchange (CM10) and strong
anion exchange (Q10) protein chip were selected for
further analysis, which displayed the best protein profile.
Mass accuracy was calibrated externally by using All-In-
One peptide and All-In-One protein molecular mass
standard (CiphergenBiosystems). All-in-One-Protein
Standard II consisted of [Hirudin, recombinant (6,964
Da)], [Cytochrome C (bovine) (12,230 Da)], [Myoglobin
(equine) (16,951 Da)], [Carbonic anhydrase (bovine red
blood cells (RBC) (29,023 Da)], [Enolase (S. cerevisiae)
(46,671 Da)], [Albumin (bovine) (66,433 Da)] and [IgG
(bovine) (147,300 Da)]. The mass spectra of proteins
were generated by using an average of 175 laser shots at
a laser intensity of 225 to 250 arbitrary units and laser
energy of 7000 nJ. To stabilize variation in sample load-
ing, the data was further normalized to total ion current
and aligned. Analyses included automatic peak detec-
tion, baseline subtraction and mass accuracy calibration.
Each of three samples of untreated PC-3 cell lysates,
DMSO extract of propolis (DEP)-treated PC-3 cells and
water extract of propolis (WEP)-treated PC-3 cells were
loaded to CM10 and Q10 ProteinChips. Samples were
analyzed in duplicate with the SELDI Protein-Chip sys-
tem (PCS 4000 Systems-CiphergenBiosystems) to obtain
a proteomic profile with molecular masses ranging from
0.3 to 50 kDa. Resulting chip data was analysed by using
Ciphergen Express Software v.3.0.
Weak cation exchange ProteinChip (CM10 chip)
The array spots were first pre-equilibrated twice with
150 μL of binding buffer (50 mM ammonium acetate
(pH 4) + 0.1% Triton X-100) for 5 min at room tem-
perature. Then, 90 μL of cell lysate which was denatu-
rated with DTT containing denaturation buffer (9 M
urea, 2% CHAPS, 2 mM DTT, 150 mM Tris-HCl, pH 9)
and diluted (1:3) in the binding buffer, was applied to
CM10 ProteinChip spot in duplicate and incubated for
1 h at room temperature. After incubation, each array
was washed three times with 150 μL of binding buffer
(5 min), and rinsed once with 200 μLo fd e i o n i z e d
water. After air drying, 1 μL of saturated solution of
sinapinic acid (SPA) in 50% acetonitrile: 0.5% TFA (v/v)
was applied on spots and allowed to air dry. The mass
spectra of proteins were analysed by the principle of
time-of-flight (TOF) using SELDI-TOF MS.
Strong Anion exchange ProteinChip (Q10 chip)
For the detection of protein profiles of the samples
using Q10 ProteinChip Array, 150 μLo fb i n d i n gb u f f e r
(50 mM Tris-HCl, pH 8) was added to each spot and
incubated for 5 min at room temperature. The above
steps were repeated twice. Then, 90 μL of cell lysate
diluted (1:3) in the binding buffer before, was applied to
Q10 ProteinChip spot in duplicate and incubated for 1
h at room temperature. After incubation, it was washed
three times with 150 μL of the binding buffer and then
rinsed once with 200 μL of deionized water. Finally,
after air drying, 1 μL of saturated solution of SPA was
added to each protein-loaded spot and allowed to air
dry. The mass spectra of proteins were analysed using
SELDI-TOF MS.
Statistical analysis
Protein peaks were clustered with the Ciphergen
Express software, version 3.0 performing Expression Dif-
ference Mapping (EDM). Proteomic features were
labeled with 5.0 S/N (signal to noise ratio), 3 valley
depth for the first pass; minimal peak threshold: 20% of
all spectra and 3.0 S/N and 1 valley depth for the sec-
ond pass with 0.3% cluster mass window. Discriminatory
peaks were identified using the Mann-Whitney non-
parametric test depending on peak intensities. Statisti-
cally significant discriminatory peaks between groups
were determined with area under receiver operating
characteristics curves (AUROC) > 0.8 and p < 0.05.
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